Literature DB >> 27643740

Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.

Sri L H Yeruva1, Yonette Paul1, Patricia Oneal1, Mehdi Nouraie2.   

Abstract

Renal dysfunction in sickle cell disease is not only a chronic comorbidity but also a mortality risk factor. Though renal dysfunction starts early in life in sickle cell patients, the predictors that can identify sickle cell disease patients at risk of developing renal dysfunction is not known. We used the Truven Health MarketScan® Medicaid Databases from 2007 to 2012. Incidence of new acute renal failure (ARF) and chronic kidney disease (CKD) was calculated in this cohort. There were 9481 patients with a diagnosis of sickle cell disease accounting for 64,201 hospital admissions, during the study period. Both ARF and CKD were associated with higher risk of inpatient mortality, longer duration of the hospital stay and expensive hospitalizations. The yearly incidence of new ARF in sickle cell disease patients was 1.4% and annual CKD incidence was 1.3%. The annual rate of new ARF and CKD in the control group was 0.4 and 0.6%, respectively. The most important predictors of new CKD were proteinuria, ARF and hypertension. Chronic kidney disease, hypertension and sickle cell crisis were the most important predictors of new ARF. The annual rate of incidences of ARF and CKD were 2- to 3-fold higher in sickle cell disease compared to the non sickle cell disease group. Besides the common risk factors for renal disease in the general population, it is imperative to monitor the sickle cell disease patients with more severe disease to prevent them from developing renal dysfunction.

Entities:  

Keywords:  Administrative database; length of hospital stay; mortality; renal failure; sickle cell disease

Mesh:

Year:  2016        PMID: 27643740      PMCID: PMC5207341          DOI: 10.1080/03630269.2016.1224766

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  26 in total

1.  The cost of health care for patients with sickle cell disease.

Authors:  Samir K Ballas
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

2.  National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.

Authors:  Maureen M Okam; Shimon Shaykevich; Benjamin L Ebert; Alan M Zaslavsky; John Z Ayanian
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

3.  Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis.

Authors:  Mehdi Nouraie; Victor R Gordeuk
Journal:  Transfusion       Date:  2015-06-30       Impact factor: 3.157

4.  Clinical Factors Associated with Morbidity and Mortality in Patients Admitted with Sickle Cell Disease.

Authors:  K Galloway-Blake; M Reid; C Walters; J Jaggon; M G Lee
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

5.  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.

Authors:  Darleen R Powars; Linda S Chan; Alan Hiti; Emily Ramicone; Cage Johnson
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

6.  Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Barry L Shulkin; Jane S Hankins; Russell E Ware
Journal:  Am J Hematol       Date:  2012-12-17       Impact factor: 10.047

7.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

8.  Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease.

Authors:  Louis-Philippe Laurin; Patrick H Nachman; Payal C Desai; Kenneth I Ataga; Vimal K Derebail
Journal:  Nephrol Dial Transplant       Date:  2013-09-30       Impact factor: 5.992

Review 9.  An update on sickle cell nephropathy.

Authors:  Abdullah Alhwiesh
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-03

10.  Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.

Authors:  Joanne Thompson; Marvin Reid; Ian Hambleton; Graham R Serjeant
Journal:  Arch Intern Med       Date:  2007-04-09
View more
  15 in total

1.  CE: Understanding the Complications of Sickle Cell Disease.

Authors:  Paula Tanabe; Regena Spratling; Dana Smith; Peyton Grissom; Mary Hulihan
Journal:  Am J Nurs       Date:  2019-06       Impact factor: 2.220

Review 2.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

3.  The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Authors:  Courtney D Fitzhugh; Mark C Walters
Journal:  Blood Adv       Date:  2017-12-08

4.  Sex differences in the trajectory of glomerular filtration rate in pediatric and murine sickle cell anemia.

Authors:  Malgorzata Kasztan; Inmaculada Aban; Suraj P Hande; David M Pollock; Jeffrey D Lebensburger
Journal:  Blood Adv       Date:  2020-01-28

Review 5.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

6.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

7.  Acute Kidney Injury among Black Patients with Sickle Cell Trait and Sickle Cell Disease.

Authors:  Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Sagar U Nigwekar; Sahir Kalim
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-08       Impact factor: 8.237

8.  Using Machine Learning to Predict Early Onset Acute Organ Failure in Critically Ill Intensive Care Unit Patients With Sickle Cell Disease: Retrospective Study.

Authors:  Akram Mohammed; Pradeep S B Podila; Robert L Davis; Kenneth I Ataga; Jane S Hankins; Rishikesan Kamaleswaran
Journal:  J Med Internet Res       Date:  2020-05-13       Impact factor: 5.428

9.  All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study.

Authors:  Kunjan Udani; Nayda Parisio-Poldiak; Julia Campbell; Victor Collier; Pooja Patel
Journal:  Cureus       Date:  2021-05-16

10.  Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment.

Authors:  Richard A Preston; Thomas Marbury; Ganesh Balaratnam; Michelle Green; Sandy Dixon; Josh Lehrer-Graiwer; Carla Washington
Journal:  J Clin Pharmacol       Date:  2020-10-20       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.